{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:13:05Z","timestamp":1793459585203,"version":"4.5.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR BRC","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K020706\/1"],"award-info":[{"award-number":["MR\/K020706\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L019027\/1"],"award-info":[{"award-number":["MR\/L019027\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155631","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T13:34:33Z","timestamp":1464701673000},"page":"e0155631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":101,"title":["Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-8955","authenticated-orcid":true,"given":"Emilio","family":"Fernandez-Egea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra E.","family":"V\u00e9rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun M.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G. C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"issue":"7256","key":"ref1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"H Stefansson","year":"2009","journal-title":"Nature"},{"issue":"7510","key":"ref2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"BN van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref4","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","author":"SG Fillman","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nbt.2777","article-title":"Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium","volume":"32","author":"V Brusic","year":"2014","journal-title":"Nature biotechnology"},{"key":"ref6","article-title":"Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies","author":"BJ Miller","year":"2012","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.biopsych.2013.10.023","article-title":"Is there a flame in the brain in psychosis?","volume":"75","author":"CS Carter","year":"2014","journal-title":"Biological psychiatry"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nri2566","article-title":"Reflex control of immunity","volume":"9","author":"KJ Tracey","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nri3280","article-title":"Pro-cognitive properties of T cells","volume":"12","author":"J Kipnis","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","article-title":"Role of dopamine in the physiology of T-cells and dendritic cells","volume":"216","author":"R Pacheco","year":"2009","journal-title":"Journal of neuroimmunology"},{"issue":"6052","key":"ref11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1209985","article-title":"Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit","volume":"334","author":"M Rosas-Ballina","year":"2011","journal-title":"Science (New York, NY)"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"BJ Miller","year":"2013","journal-title":"Biol Psychiatry"},{"key":"ref13","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","author":"J Steiner","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"RC Drexhage","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2\u20133","key":"ref15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2006.06.004","article-title":"T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment","volume":"152","author":"K Maino","year":"2007","journal-title":"Psychiatry research"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0920-9964(98)00175-3","article-title":"T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients","volume":"38","author":"B Sperner-Unterweger","year":"1999","journal-title":"Schizophrenia Research"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"HT Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-1-62703-059-5_23","article-title":"Partial least squares methods: partial least squares correlation and partial least square regression","volume":"930","author":"H Abdi","year":"2013","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"S Miyamoto","year":"2012","journal-title":"Mol Psychiatry"},{"key":"ref20","year":"2011"},{"key":"ref21","first-page":"1","year":"2014"},{"issue":"6004","key":"ref22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1191506","article-title":"Research funding. Sustaining the data and bioresource commons","volume":"330","author":"PN Schofield","year":"2010","journal-title":"Science"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000092678","article-title":"Cannabis-induced psychosis-like experiences are associated with high schizotypy","volume":"39","author":"EJ Barkus","year":"2006","journal-title":"Psychopathology"},{"issue":"2\u20133","key":"ref24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"RSE Keefe","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"416","key":"ref25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"JM Haro","year":"2003","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/08923973.2013.828744","article-title":"Regulation of macrophage immune responses by antipsychotic drugs","volume":"35","author":"ML Chen","year":"2013","journal-title":"Immunopharm Immunot"},{"key":"ref27","article-title":"Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far?","author":"R R\u00f8ge","year":"2012","journal-title":"Schizophrenia Research"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"e104430","DOI":"10.1371\/journal.pone.0104430","article-title":"Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis","volume":"9","author":"D O'Sullivan","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/08923973.2011.651535","article-title":"Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-\u03b3 production in peripheral blood mononuclear cells","volume":"34","author":"M-L Chen","year":"2012","journal-title":"Immunopharm Immunot"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbi.2012.01.018","article-title":"Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels","volume":"26","author":"J Steiner","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"W Beumer","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","article-title":"Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients","volume":"13","author":"RC Drexhage","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1371\/journal.pone.0000692","article-title":"Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms","volume":"2","author":"RM Craddock","year":"2007","journal-title":"PLoS ONE"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-9964(97)00153-9","article-title":"Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients","volume":"31","author":"CL Cazzullo","year":"1998","journal-title":"Schizophrenia Research"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","article-title":"CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages","volume":"9","author":"JR Fergusson","year":"2014","journal-title":"Cell Rep"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00213-010-2087-1","article-title":"Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment","volume":"214","author":"KD Ersche","year":"2011","journal-title":"Psychopharmacology"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","article-title":"The potential role of dopamine D(3) receptor neurotransmission in cognition","volume":"23","author":"S Nakajima","year":"2013","journal-title":"Eur Neuropsychopharm"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"OD Howes","year":"2009","journal-title":"Schizophr Bull"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"S Kapur","year":"2003","journal-title":"The American journal of psychiatry"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.1103096","article-title":"Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity","volume":"188","author":"C Prado","year":"2012","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2005.11.018","article-title":"D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells","volume":"173","author":"E-M Boneberg","year":"2006","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","article-title":"Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop","volume":"109","author":"M Cosentino","year":"2007","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-2-3","article-title":"Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients","volume":"2","author":"YT Kwak","year":"2001","journal-title":"BMC medical genetics"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpsychires.2012.03.004","article-title":"Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity","volume":"46","author":"GEA Brito-Melo","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s11033-010-0396-4","article-title":"Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?","volume":"38","author":"M Urhan-Kucuk","year":"2011","journal-title":"Molecular biology reports"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","article-title":"Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease","volume":"46","author":"Y Nagai","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"T Ilani","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7110","key":"ref48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature05071","article-title":"Centrosome polarization delivers secretory granules to the immunological synapse","volume":"443","author":"JC Stinchcombe","year":"2006","journal-title":"Nature"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/187152410790780154","article-title":"Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands","volume":"10","author":"R Pacheco","year":"2010","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"1\u20133","key":"ref50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"V Tourjman","year":"2013","journal-title":"Schizophrenia research"},{"issue":"1","key":"ref51","article-title":"Genetic and Clinical Factors Affecting Plasma Clozapine Concentration","volume":"17","author":"E Olsson","year":"2015","journal-title":"The primary care companion for CNS disorders"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biopsych.2013.12.006","article-title":"Immunologic therapeutics and psychotic disorders","volume":"75","author":"ET Bullmore","year":"2014","journal-title":"Biological psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T22:35:53Z","timestamp":1567982153000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155631"}},"subtitle":[],"editor":[{"given":"Vassiliki A","family":"Boussiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}